FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Free FDA Notices
FDA Withdraws Impax Labs’ Budeprion XL
03/18/2013
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
Sen. Cassidy Challenges FDA on CDS Oversight
3rd Eugia FDA-483 This Year So Far
Lilly Filing NDA for Expanded Tirzepatide Use
FDA Reports on Device Safety, Innovation
Restrictions on Lutathera ANDA Sought
Sun Pharma Hit With 483 After India Inspection
Its Official: Oncopeptides Pepaxto is Withdrawn
FDA Denies Generic Imodium Petition
LATEST NEWS
Read More
Medical Devices
Sen. Cassidy Challenges FDA on CDS Oversight
Read More
Human Drugs
3rd Eugia FDA-483 This Year So Far
Read More
Human Drugs
Lilly Filing NDA for Expanded Tirzepatide Use
Read More
Medical Devices
FDA Reports on Device Safety, Innovation
FDA Webview Free Daily e-Newsletter
Free Sign-Up
